T1	Participants 96 158	elderly adults with newly diagnosed acute myelogenous leukemia
T2	Participants 204 272	elderly adults with newly diagnosed acute myelogenous leukemia (AML)
T3	Participants 452 558	84 adults (age range, 70-90 years; median, 76 years) who were not candidates for conventional chemotherapy
T4	Participants 1141 1194	41 patients treated with conventional chemotherapies.
T5	Participants 935 968	40 patients treated with T plus E
